Company: INMB
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001213900-25-104141
Chunk: 203

Company: Inmune Bio, Inc.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 6
Chunk 203
---
Item 6. Exhibits 

    No.
     
    Description 

    31.1
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer*

    31.2
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*

    32.1
     
    Section 1350 Certification of Principal Executive Officer**

    32.2
     
    Section 1350 Certification of Chief Financial Officer**

    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    *
    Filed herewith.

    **
    Furnished herewith.

35

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    INmune Bio Inc. 

    Date: October 30, 2025
    By:
    /s/ David Moss

    David Moss

    Chief Executive Officer

    (Principal Executive Officer)

    Date: October 30, 2025 
    By:
    /s/ Cory Ellspermann

    Cory Ellspermann

    Chief Financial Officer

    (Principal Financial and Accounting Officer)

36

0001711754
false
Q3
--12-31

    0001711754

    2025-01-01
    2025-09-30

    0001711754

    2025-10-30

    0001711754

    2025-09-30

    0001711754

    2024-12-31

    0001711754
    
      us-gaap:RelatedPartyMember